GR851423B - - Google Patents

Info

Publication number
GR851423B
GR851423B GR851423A GR850101423A GR851423B GR 851423 B GR851423 B GR 851423B GR 851423 A GR851423 A GR 851423A GR 850101423 A GR850101423 A GR 850101423A GR 851423 B GR851423 B GR 851423B
Authority
GR
Greece
Prior art keywords
alpha
pharmaceutically acceptable
acceptable salt
imidazole
chlorophenyl
Prior art date
Application number
GR851423A
Other languages
Greek (el)
Inventor
Kenneth Steven Hirsch
Harold Mellon Taylor
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GR851423B publication Critical patent/GR851423B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Epoxy Resins (AREA)
  • Steroid Compounds (AREA)

Abstract

This invention provides imidazole derivatives of the formula <CHEM> wherein Q is hydrogen or hydroxy and R1 and R2 are independently F or Cl, or a pharmaceutically acceptable salt thereof. alpha , alpha -Bis(4-chlorophenyl)-1H-imidazole-4(5)-methanol, or a pharmaceutically acceptable salt thereof, and their pharmaceutical formulations which are useful in inhibiting aromatase or treating or preventing estrogen-dependent diseases in mammals.
GR851423A 1984-06-18 1985-06-11 GR851423B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62159784A 1984-06-18 1984-06-18

Publications (1)

Publication Number Publication Date
GR851423B true GR851423B (en) 1985-11-25

Family

ID=24490833

Family Applications (1)

Application Number Title Priority Date Filing Date
GR851423A GR851423B (en) 1984-06-18 1985-06-11

Country Status (17)

Country Link
EP (1) EP0168965B1 (en)
JP (1) JPS6112667A (en)
KR (1) KR860000267A (en)
AT (1) ATE38516T1 (en)
AU (1) AU4373785A (en)
CA (1) CA1238640A (en)
DE (1) DE3566115D1 (en)
DK (1) DK269785A (en)
ES (1) ES8704464A1 (en)
GR (1) GR851423B (en)
HU (1) HU195190B (en)
IL (1) IL75487A0 (en)
NZ (1) NZ212389A (en)
PH (1) PH21210A (en)
PT (1) PT80628B (en)
SU (1) SU1398774A3 (en)
ZA (1) ZA854400B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85747A1 (en) * 1985-01-28 1986-08-04 Continental Pharma IMIDAZOLE DERIVATIVES, PREPARATION AND USE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES
GB2229719B (en) * 1989-03-30 1992-04-29 Farmos Oy Novel aromatase inhibiting 4(5)-imidazoles
PE20010781A1 (en) 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd COMPOUNDS 1- (1H-IMIDAZOL-4-IL) -1- (NAFTIL-2-SUBSTITUTED) ETHANOL, ITS PRODUCTION AND USE
EP2250153B1 (en) * 2008-01-18 2013-06-19 Allergan, Inc. Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946804A (en) * 1958-12-29 1960-07-26 Abbott Lab (5-methyl-4-imidazolyl)-diphenyl carbinol salts and lower alkyl quaternaries
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
ES544133A0 (en) 1987-04-01
CA1238640A (en) 1988-06-28
KR860000267A (en) 1986-01-27
IL75487A0 (en) 1985-10-31
JPS6112667A (en) 1986-01-21
DK269785D0 (en) 1985-06-14
EP0168965A1 (en) 1986-01-22
DK269785A (en) 1985-12-19
ES8704464A1 (en) 1987-04-01
DE3566115D1 (en) 1988-12-15
PT80628B (en) 1987-04-28
ATE38516T1 (en) 1988-11-15
HU195190B (en) 1988-04-28
PH21210A (en) 1987-08-19
ZA854400B (en) 1987-02-25
AU4373785A (en) 1986-01-02
SU1398774A3 (en) 1988-05-23
EP0168965B1 (en) 1988-11-09
NZ212389A (en) 1987-11-27
PT80628A (en) 1985-07-01
HUT38320A (en) 1986-05-28

Similar Documents

Publication Publication Date Title
NO174508C (en)
CA2004154A1 (en) 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxyphenyl 1,2,4-thiadiazoles, oxadiazoles and triazoles as anti-inflammatory agents
RU1833372C (en) Method of synthesis of 2,4,5-substituted of benzene
MY103241A (en) Imidazole and 1,2,4 triazole derivatives
NZ332136A (en) Phenylalkylcarboxylic acid derivatives useful for treating hyperglycemia
PH24309A (en) Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)-ergolines and pharmaceutical formulations thereof
GR851423B (en)
NZ222640A (en) Quinolinol derivatives and pharmaceutical compositions
PT85358B (en) Process for the preparation of improved fungicidal compositions containig a synergic mixture of alpha-(4-chlorophenyl)-alpha- (1-cyclopropylethyl)-1h-1,2,4-thiazole-1-ethanol with 1,1&#39;-im ine-dicoctamethylene-diguanidine and/or their salts
HU9400908D0 (en) Pharmaceutical compositions for treatng skin disorders
EP0285284A3 (en) N-phenethylaminoalkyl-benzamide anti-arrhythmia agents
NZ220967A (en) 4-nitrogen substituted isoquinolin-3-ol derivatives and pharmaceutical compositions
GR3017435T3 (en) Antihypertensive 3-piperidinyl-indazole derivatives.
SG4595G (en) Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure
ZA889070B (en) Novel azole compounds
SU1299112A1 (en) 3-Methyl-5 - [(5-nitrofurfuryl-2) -thio] -1,2,4-triazole or its hydrochloride, possessing antimicrobial, analgesic and anti-inflammatory activity